In an earlier blog I referenced the 2006 Combating Autism Act. Among other investments the law created the Inter Agency Autism Coordinating Committee or IACC. It is made up of 18 seats. Twelve members are government representatives and six members are from the general public. The IACC is responsible for developing and updating the Strategic Plan for Autism Research under the mandate of the Combating Autism Act. They decide which studies get funding from the $940 million that was allocated to autism research under the Act.
The members are:
Chair
Thomas R. Insel, M.D.
Director
National Institute of Mental Health
National Institutes of Health
Bethesda, Maryland
Federal Members
James F. Battey, M.D., Ph.D.
Director
National Institute on Deafness and Other Communication
Disorders
National Institutes of Health
Bethesda, Maryland
Linda Birnbaum, Ph.D.
Director
National Institute of Environmental Health Sciences
National Institutes of Health
Research Triangle Park, North Carolina
Ellen W. Blackwell, M.S.W.
Division of Community and Institutional Services
Disabled and Elderly Health Programs Group
Center for Medicaid and State Operations
Centers for Medicare and Medicaid Services
Baltimore, Maryland
Coleen Boyle, Ph.D.
Acting Director
National Center on Birth Defects and Developmental
Disabilities
Centers for Disease Control and Prevention
Atlanta, Georgia
Henry Claypool
Director
Office on Disability
U.S. Department of Health and Human Services
Washington, DC
Francis S. Collins, M.D., Ph.D.
Director
National Institutes of Health
Bethesda, Maryland
Alan E. Guttmacher, M.D.
Director
Eunice Kennedy Shriver National Institute of Child Health
and Human Development
Bethesda, Maryland
Gail R. Houle, Ph.D.
Associate Division Director
Research-to-Practice Division
Early Childhood Programs
Office of Special Education Programs
U.S. Department of Education
Washington, DC
Larke N. Huang, Ph.D.
Senior Advisor on Children
Office of the Administrator
Substance Abuse and Mental Health Services Administration
Rockville, Maryland
Walter J. Koroshetz, M.D.
Deputy Director
National Institute of Neurological Disorders and Stroke
Bethesda, Maryland
Sharon Lewis
Commissioner
Administration on Developmental Disabilities
Administration for Children and Families
Washington, DC
Peter van Dyck, M.D., M.P.H.
Associate Administrator
Maternal and Child Health
Health Resources and Services Administration
Rockville, Maryland
Public Members
Geraldine Dawson, Ph.D.
Chief Science Officer
Autism Speaks
New York, New York
Gerald D. Fischbach, M.D.
Scientific Director
Simons Foundation Autism Research Initiative
New York, New York
Lee Grossman
President and CEO
Autism Society
Bethesda, Maryland
Yvette M. Janvier, M.D.
Medical Director
Children's Specialized Hospital
Toms River, New Jersey
Christine M. McKee, J.D.
Rockville, Maryland
Ari Ne'eman
Founding President
Autistic Self-Advocacy Network
Washington, DC
Lyn Redwood, R.N., M.S.N.
Co-Founder and Executive Director
Coalition for SafeMinds
Tyrone, Georgia
Denise D. Resnik
Board Member and Co-Founder
Southwest Autism Research and Resource Center
Phoenix, Arizona
Stephen M. Shore, Ed.D.
Executive Director
Autism Spectrum Disorder Consulting and
Assistant Professor of Special Education
Adelphi University
Newton, Massachusetts
Alison Tepper Singer, M.B.A.
President
Autism Science Foundation
New York, New York
Marjorie Solomon, Ph.D., M.B.A.
Assistant Clinical Professor
University of California, Davis
School of Medicine and
M.I.N.D. Institute
Sacramento, California
Next we will discuss research completed as authotized by the IACC in 2010 on treatment effectiveness.
|